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Abstract
Hypertension in humans and experimental models has a strong hereditary basis, but identification
of causative genes remains challenging. Quantitative trait loci (QTLs) for hypertension and salt
sensitivity have been reported on rat chromosome 18. We set out to genetically isolate and
prioritise genes within the salt sensitivity and hypertension QTLs on the spontaneously
hypertensive rat (SHR) chromosome 18, by developing and characterising a series of congenic
strains derived from the SHR and normotensive Brown Norway (BN) rat strains. The SHR.BN-
D18Rat113/D18Rat82 (SHR-18) congenic strain exhibits significantly lower blood pressure and is
salt-resistant compared to SHR. Transplantation of kidneys from SHR-18 donors into SHR
recipients is sufficient to attenuate increased blood pressure but not salt sensitivity. Derivation of
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congenic sublines allowed separation of salt sensitivity from hypertension QTL regions. Renal
expression studies with microarray and Solexa-based sequencing in parental and congenic strains
identified four differentially expressed genes within the hypertension QTL region, one of which is
an unannotated transcript encoding a previously undescribed, small non-coding RNA. Sequencing
selected biological candidate genes within the minimal congenic interval revealed a non-
synonymous variant in SHR Transcription factor 4. The minimal congenic interval is syntenic to a
region of human chromosome 18 where significant linkage to hypertension was observed in
family-based linkage studies. These congenic lines provide reagents for identifying causative
genes that underlie the chromosome 18 SHR QTLs for hypertension and salt sensitivity. Candidate
genes identified in these studies merit further investigation as potentially causative hypertension
genes in SHR and human hypertension.
Keywords
hypertension; salt sensitivity; congenic; microarray expression profiling; candidate genes
INTRODUCTION
Essential hypertension is highly prevalent throughout the world and represents a major risk
factor for coronary heart disease, kidney failure and stroke.1 However, the molecular genetic
basis of essential hypertension remains largely unknown.2,3 The elucidation of genes
responsible for human essential hypertension is especially challenging given the failure to
identify statistically significant, replicated association by genome-wide association
analysis.4 Inbred animal models can be used to identify genes and pathways for complex
cardiovascular traits for which the orthologous genes and pathways may contribute to the
related human trait.5–8 The spontaneously hypertensive rat (SHR) is a widely used animal
model of essential hypertension and also develops salt sensitive hypertension. Salt
sensitivity, defined as an increase in blood pressure with increased dietary salt, is found in
50–70% of human patients with essential hypertension.9
In this study, we set out to genetically isolate and prioritise the genes within the salt
sensitivity and hypertension quantitative trait loci (QTLs) on SHR chromosome 18, by
developing and characterising a series of congenic strains in which we transferred the
corresponding region of chromosome 18 from the normotensive and salt resistant Brown
Norway (BN) rat onto the genetic background of the salt sensitive SHR/Ola strain.
MATERIALS AND METHODS
SHR Congenic Strain and Subline Derivation
All animal studies were performed in agreement with the institutional animal care and use
committee at the University of California, San Francisco and Animal Protection Law of the
Czech Republic (311/1997); approved by the Ethics Committee of the Institute of
Physiology, Czech Academy of Sciences, Prague. SHR/Ola rats were from the Prague
colony and Brown Norway (BN/Crl) rats from Charles River Laboratories (Wilmington
MA, USA). Please see http://hyper.ahajournals.org for details of the construction of these
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congenic strains. The physical and genetic coordinates of the markers defining the SHR and
BN limits in the four congenic lines are shown in Figure 1.
Blood Pressure Measurements
Arterial blood pressures were measured continuously by radiotelemetry in paired
experiments between conscious, unrestrained SHR parental and age-matched congenic male
rats. Pulsatile pressures were recorded as previously described.10 To test for salt sensitivity,
blood pressure measurements were taken for six days when rats were given 1% NaCl for
drinking instead of tap water at 15 to 17 weeks of age for SHR-18, SHR-18B, and SHR-18C
and from 19 to 21 weeks of age for SHR-18A. Comparison of radiotelemetry data between
congenic and parental strain was carried out by two-way fixed ANOVA with one grouping
factor for strains and one trial factor for blood pressure measurements at baseline and during
1% NaCl administration. F statistics and P values corresponding to the main effects for
strain and trial factor effect for a strain are reported. Salt preference in SHR and SHR-18
strains was measured by a standard two bottle test to determine whether any differences in
salt sensitivity were associated with differences in salt appetite. Please see http://
hyper.ahajournals.org for details of blood pressure measurements and statistical analyses.
Kidney Transplantation
Kidney transplantation experiments were performed using methods similar to those
previously described.11 Transplantation procedures were performed in 9–11 week old male
SHR progenitor strain with donor kidneys from either the SHR-18 congenic or the SHR
progenitor strain. Transplant recipients were bilaterally nephrectomised SHR.
Radiotelemetry transducers were implanted at 14–17 weeks of age and baseline blood
pressures were taken at 18–20 weeks of age. To test for salt sensitivity, blood pressure
measurements were taken for eight days when rats were given 1% NaCl for drinking instead
of tap water at 19 to 21 weeks of age. At 23 weeks of age, transplant recipients were tested
for renal function by determining glomerular filtration rates (GFR) and urine protein/
creatinine ratios. Please see http://hyper.ahajournals.org for details of renal function tests
and statistical analyses of blood pressure measurements taken before and during salt loading.
Microarray and Solexa Analyses
For generation of microarray data, RNA was extracted from 4 pairs of whole kidneys from
SHR/Ola, BN/Crl, and SHR-18 males. For Solexa data, RNA was extracted from 3 pairs of
whole kidneys from SHR/Ola, SHR-18 and SHR-18B males. Please see http://
hyper.ahajournals.org for details of preparation of the RNA, statistical analyses for the
microarray and Solexa analysis, and the mapping and validation of the Solexa analyses. The
microarray data set has been submitted to ArrayExpress and can be accessed at http://
ebi.ac.uk/ (Experimental Accession No. E-MIMR-1122).
5′ and 3′ Rapid Amplification of cDNA Ends (RACE) of rc_AA957526_at
The 5′ and 3′ sequence of rc_AA957526_at was determined by cloning and sequencing.
Homologous sequences from human, mouse, dog and opossum genomic DNA were aligned
to the rat sequence. To identify conserved small RNA, the multi-species alignment was run
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in the RNAz web server12 using the default parameters except for a basic window size of
200bp. Northern blots from BN and SHR kidney small RNA (<200bp) was probed with a
single-stranded oligonucleotide probe. Please see http://hyper.ahajournals.org for details of
the RACE procedure, in silico prediction, validation and Northern blotting. The 1.8kb
sequence has been submitted to GenBank (http://www.ncbi.nlm.nih.gov/Genbank/
index.html) (GenBank accession number FJ479701).
RT-PCR, DNA Sequencing and Restriction Fragment Length Polymorphism (RFLP)
Analyses
SHR/Ola and BN/Crl genomic DNA and kidney random hexamer-primed cDNA served as
templates for PCR and RT-PCR to amplify the protein coding regions of seven genes within
the blood pressure QTL interval. Primers are listed in Table S1. The Transcription factor 4
(Tcf4) single nucleotide polymorphism (SNP) was tested in the genomic DNA of SHR,
SHR-18, SHR-18B and 25 commonly used rat strains including the hypertensive strains
SHR-Stroke Prone (SHRSP) and Dahl Salt-Sensitive (SS/Jr) using standard methods. Please
see http://hyper.ahajournals.org for details of the amplification and RFLP protocols.
RESULTS
Mapping the Blood Pressure and Salt Sensitivity QTLs in Congenic Strains
Systolic and diastolic blood pressures in the congenic lines were compared (in paired
experiments) to age-matched SHR controls at baseline and during days 4 and 5 of 1% NaCl
administration (salt loading). At baseline, SHR-18, SHR-18A and SHR-18B showed lower
systolic blood pressure compared to SHR controls whereas the SHR-18C strain showed
similar systolic blood pressure levels to SHR (Figure 2). Salt loaded systolic blood pressure
was significantly raised in all SHR and congenic strains with the exception of SHR-18
(Figure 2). Diastolic blood pressure did not show the same pattern as systolic blood pressure
due to the large variation and narrower ranges associated with diastolic blood pressure
(Figure S1). These data indicate the presence of blood pressure regulatory gene(s) within the
SHR-18B congenic interval, excluding the region of overlap between SHR-18B and
SHR-18C, as defined by the region between markers D18Rat40 and D18Rat82 (Figure 1).
This region contains 88 protein coding genes in the Ensembl genome database (http://
www.ensembl.org/Rattus_norvegicus/Info/Index). Similarly, the data indicate the presence
of salt sensitivity susceptibility gene(s), located within the chromosomal interval defined by
markers D18Rat113 and D18Rat99 (Figure 1). There was no significant difference in fluid
consumption between the SHR-18 congenic strains and the SHR strain when corrected for
body weight. Similarly, SHR (n=8) and SHR-18 (n=6) did not differ for their preference for
salt (81.3% ± 3.7 versus 82.9% ± 4.7).
Kidney Transplantation
To test whether the blood pressure and salt sensitivity phenotypes are determined by genes
expressed either within or outside the kidney, systolic and diastolic blood pressures were
compared between bilaterally nephrectomised SHR recipients that were transplanted with
either a kidney from SHR-18 congenic rats (SHRSHR-18) (n= 8) or from SHR rats (SHRSHR)
(n=5). In the basal state prior to salt loading, the SHRSHR-18 animals had lower systolic
Johnson et al. Page 4
Hypertension. Author manuscript; available in PMC 2014 June 05.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
blood pressures when compared to SHRSHR controls (Figure 3). The nephrectomised and
transplanted SHRSHR-18 and SHRSHR rats showed highly significant rises in systolic blood
pressure as a result of salt loading (Figure 3). Diastolic blood pressure did not show the
same pattern as systolic blood pressure due to the large variation and narrower ranges
associated with diastolic blood pressure (Figure S2). GFR was 1.2 ± 0.2 ml/minute for both
groups. Protein urine/creatinine ratios (mg protein/mg creatinine) were 1.8 ± 0.2 for
SHRSHR-18 animals and 1.7 ± 0.2 for SHRSHR animals.
Gene Expression Analysis by Microarrays, Solexa Tag Analysis and quantitative RT-PCR
(qRT-PCR)
To identify differentially expressed kidney transcripts within the congenic region of the
SHR-18 congenic strain, gene expression analysis of the SHR, BN and SHR-18 kidney
transcriptome was carried out with Affymetrix U34A-C microarrays. After filtering the
microarray data for probe sets mapping to multiple locations in the genome, 88 transcripts
were identified to be differentially expressed between SHR and BN of which 2 mapped to
the SHR-18 and SHR-18B congenic interval that the blood pressure studies delineated as the
minimal congenic interval for the SHR QTL hypertension gene(s) (p=0.05, FDR=0.05)
(Table S2). Comparison of the SHR and SHR-18 strains identified 26 differentially
expressed transcripts of which 2 mapped within the SHR-18 congenic interval and 1 within
the SHR-18B congenic interval (p=0.05, FDR=0.05) (Table S3). Common to both the
SHR/BN comparison and the SHR/SHR-18 comparison was a single unannotated transcript,
rc_AA957526_at, which was 6.6 fold higher expressed in SHR compared to BN and 4.9 fold
higher expressed in SHR compared to SHR-18 with P values of 3.5 × 10−9 and 8.2 × 10−10
respectively (Table S2, S3). Nineteen genes from the SHR-18B minimal blood pressure
congenic interval were represented by microarray. To extend the microarray expression
analysis and identify an unbiased set of differentially expressed transcripts within the blood
pressure QTL interval, we carried out Solexa-based sequencing of the SHR, SHR-18 and
SHR-18B kidney transcriptomes. Of 252 tags (representing 32 genes) that map within the
SHR-18B congenic region, 69 (representing 15 genes) had a fold change of tag abundance
≥1.5 when SHR was compared to SHR-18 and SHR-18B. Five of these tags were found to
be significantly differentially expressed (p<0.05) between SHR and SHR-18 and also
between SHR and SHR-18B. The directional differential expression of three of these tags
was confirmed by qRT-PCR (Figure S3). The list of tags that map within the blood pressure
QTL interval and had a fold change of tag abundance ≥1.5 are given in Table S4.
Characterisation of rc_AA957526_at
Because the probe set representing the differential expressed transcript rc_AA957526_at
mapped within both SHR-18 and SHR-18B differential segments, but was not a previously
annotated gene, we carried out 5′ and 3′ RACE to determine its full-length sequence. The 5′
and 3′ RACE fragments formed an intronless 1.8kb sequence which did not have an open
reading frame with homology to any known mammalian proteins. Semi-quantitative RT-
PCR in SHR, SHR-18 and SHR-18B kidney cDNA confirmed the existence the 1.8kb
differentially expressed transcript (Figure S4). When RT-PCR products were normalised to
Gapdh, SHR-18 and SHR-18B had 1.2 and 1.6 fold less transcript compared to SHR,
confirming higher expression in the SHR. The 1.8kb RACE sequence showed high
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conservation of 73, 85, 74 and 67% in genomic DNA from human, mouse, dog and opossum
respectively. Because all open reading frames lacked homology to mammalian proteins, we
considered the possibility of this conserved 1.8kb fragment representing a non-protein
coding RNA. Alignments of the rat, human, mouse, dog and opossum genomic DNA
sequences were run through the RNAz web server to find thermodynamically stable and
structurally conserved RNA elements. From a 200bp sequence within the 1.8kb fragment,
RNAz predicted the presence of a small RNA encoded from the same strand as the RNA
interrogated by the microarray (Figure S5). Northern blotting carried out in BN and SHR
kidney small RNA showed the presence of a small transcript with approximate size of 100bp
(Figure 4).
Sequence Analysis of Positional Candidate Genes
To provide an expression-independent set of candidate genes within the blood pressure QTL
region which may lead to altered protein function, we sequenced seven genes within the
minimal SHR-18B congenic region that had gene ontologies indicative of metabolic or
regulatory processes that could be related to blood pressure control. The protein coding
regions of cell death-inducing DNA fragmentation factor, alpha subunit-like effector A
(Cidea), melanocortin 2 receptor (Mc2r), melanocortin 4 receptor (Mc4r), melanocortin 5
receptor (Mc5r), protein tyrosine phosphatase, non-receptor type 2 (Ptpn2) and StAR-related
lipid transfer (START) domain containing 6 (Stard6) were identical between BN and SHR.
However, three SNPs were found in the SHR Tcf4 coding sequence when compared to BN:
G1182A, A1428G and G1984A. The G1948A sequence variant resulted in a non-
synonymous change of alanine to threonine at codon 662. We tested 25 commonly used rat
strains to determine if the variant was unique to either SHR or BN. The Tcf4 non-
synonymous sequence change was not found to be unique in BN or SHR and there was no
consistent relationship between Tcf4 genotype and hypertension across these strains.
DISCUSSION
Using congenic strains, our studies have defined regions on chromosome 18 that contain
genes for increased blood pressure and salt sensitivity in the SHR strain. Our results showed
that the SHR-18 congenic strain has pronounced salt resistance, a characteristic not shown in
other SHR congenic strains10,13–17. The effects of chromosome 18 on salt sensitivity do not
appear to be related to salt intake or fluid consumption as these were found to be similar in
SHR-18 and the SHR progenitor strain. Previous linkage studies have suggested the
presence of major QTLs on rat chromosome 18 with effects on blood pressure and/or salt
sensitivity in three rat models of human essential hypertension: SHR,18 SHRSP,18,19 and the
Dahl salt-sensitive rat (SS/Jr).20 Blood pressure and salt sensitivity QTLs have been
confirmed the SS-18BN consomic strain.21 Further congenic lines will need to be generated
to determine if these hypertension and salt sensitivity QTLs in the Dahl rat are caused by the
same genes as the QTLs that have been isolated in the SHR-18 strain.
Telemetric testing of blood pressure in the congenic strains showed that the SHR-18,
SHR-18A, SHR-18B but not SHR-18C congenic intervals contains gene(s) for increased
blood pressure in the SHR strain (Figure 1). Some or all of these SHR hypertension genes
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are therefore contained within the minimal 11.6Mbp congenic interval of SHR-18B. We
showed that bilaterally nephrectomised SHR rats transplanted with an SHR-18 kidney have
significantly lower blood pressure than bilaterally nephrectomised SHR rats transplanted
with an SHR kidney: the lower blood pressures observed in SHR animals with a
transplanted SHR-18 kidney were similar to the lower blood pressures in the
nontransplanted SHR-18 rats, thus providing evidence that the gene underlying the blood
pressure QTL is expressed within the 18–20 week old SHR-18 kidney. In contrast, the
transplanted SHR-18 kidney had no effect on salt sensitivity. The simple interpretation
would be that the transplanted SHR-18 congenic kidney with intrarenally expressed
chromosome 18 BN allele(s) is not sufficient for promoting salt-resistance in the SHR
recipient. However, it should be noted that the transplantation procedure interrupts renal
innervation and it is possible that under other experimental circumstances, for example, in
the setting of intact renal nerves, that the differential segment of chromosome 18 might
affect salt sensitivity by way of gene effects inside the kidney.
Microarray expression profiling in the kidney revealed a single transcript, represented by
probe set rc_AA957526_at, that was differentially expressed between the SHR and BN
progenitor strains, and also between the SHR and SHR-18 strains and that mapped within
the blood pressure QTL region defined by the SHR-18B congenic subline. The rat 1.8kb
extended sequence from this probe set did not have an open reading frame with homology to
mammalian proteins, but showed strong conservation across species suggesting a possible
functional significance of this transcript. In silico analyses using the RNAz web server12
found one highly conserved small RNA. Northern blotting confirmed a small RNA
transcribed from the same strand of RNA interrogated by the microarray. These data suggest
that this locus encodes a small non-protein coding RNA that could mediate a novel
mechanism for blood pressure regulation.
Solexa-based sequencing has the potential to provide a set of differentially expressed
transcripts which is unbiased because, unlike microarrays, it is not reliant upon genome
annotations or the presence of previously detected ESTs. These analyses of the kidney
transcriptome identified five tags that mapped to the SHR-18B congenic interval that
showed differential expression (tag abundance ratio ≥1.5, p<0.05) in SHR-18 and SHR-18B
when compared to SHR (Table S4). Directional differential expression of the three tags in or
close to Acetyl-CoA acyltransferase (Acaa2), Ras-related protein Rab-27B (Rab27b) and an
annotated pseudogene (LOC689364) were confirmed by qRT-PCR (Figure S3) and may
therefore be considered as attractive candidate genes for the chromosome 18 SHR blood
pressure QTLs.
It is worth noting that the Solexa tags for these three genes were not represented on the
Affymetrix microarray showing the value of the unbiased approach of Solexa sequencing
compared to microarrays. However, the Solexa-based sequencing did not identify the
putative non-protein coding RNA that was previously found to be differentially expressed
between SHR and BN,22 possibly due to the low number of tags which was found to be
similar in all three strains.
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It has been reported that the expression of Acaa2 was significantly decreased in the kidneys
of SS-18BN consomic rats compared to SS controls using microarrays and qRT-PCR.21
These results are consistent with the Solexa-based analysis when SHR-18 and SHR-18B rats
showed significantly decreased Acaa2 expression when compared to the SHR. Renal Acaa2
expression is cis-regulated in the BXH/HXB recombinant inbred strains22 and is non-
significantly correlated to systolic blood pressure (r=0.29, P=0.13) (http://
www.genenetwork.org/). Together these findings suggest that Acaa2 is a promosing
candidate for blood pressure regulation.
Because the gene(s) underlying the blood pressure QTL may not be dysregulated at the
RNA level, but may vary in activity due to coding variants between BN and SHR, we
sequenced selected genes within the SHR-18B congenic interval as an additional approach
to prioritising and characterising candidate genes. We focused our attention on genes that
may be indirectly involved in blood pressure regulation through their known and annotated
functions relating to metabolic or regulatory processes. The only coding variant found in our
selected set of genes was in Tcf4, where at amino acid 662, alanine was changed to a
threonine in SHR. The significance of this coding variant in Tcf4 is unclear because the
affected codon, although conserved in mouse, dog and human, is not within an annotated
functional domain according to InterPro. Point mutations, deletions and insertions in human
Tcf4, some creating premature stop codons have been identified in humans diagnosed with
the Pitt-Hopkins syndrome;23–25 although hypertension is not a recognised feature of this
syndrome. Tcf4 has been shown to play an important role in vascular remodelling and in
kidney development26,27 and therefore could be putatively involved in blood pressure
regulation. Whilst this sequence analysis is not a comprehensive study of all the protein-
coding genes in the minimal congenic interval, it has prioritised one gene for further study
over several other potential biological candidates.
Several genetic studies of human increased blood pressure have shown linkage or
association to genes or regions that are syntenic to the SHR-18B congenic interval.4,28–31
The human orthologues of Acaa2, Rab27b, Tcf4 and the genomic region encoding the
putative non-protein coding RNA map within 10Mbp of peak linkages for systolic blood
pressure in two family-based studies28,29 and for pulse and systolic blood pressure from the
Family Blood Pressure Program.30 These genes should therefore be considered attractive
candidate genes for these three studies. However, they map more than 10Mbp from the peak
of linkage markers for hypertension loci identified in a genome wide association study4, a
population based linkage study31 and in the Framingham Heart Study.32 Precise
identification of the SHR hypertension QTL genes isolated in the congenic strains in this
study may therefore be informative for elucidation of the linkages reported in these human
studies.
PERSPECTIVES
These congenic studies have shown that the blood pressure and salt sensitivity QTLs
previously reported on SHR chromosome 18 are encoded by separate genes on separate
chromosomal segments. Kidney transplantation studies suggest that selective expression of
allelic variants from chromosome 18 of the BN rat inside the SHR kidney is sufficient to
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attenuate increased blood pressure but not salt-sensitivity. Renal gene expression analyses
and sequencing of genes trapped within the blood pressure QTL region have identified five
candidate genes which have not been previously implicated in hypertension. Further study of
these genes will focus on detailed functional testing of these genes as determinants of the
blood pressure QTLs in the SHR strain and of linkages to the corresponding regions of the
human genome.
Supplementary Material
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Figure 1.
Genetic and physical map showing the transferred segment of chromosome 18 in the
SHR-18 congenic strain, and in the SHR-18A, SHR-18B and the SHR-18C congenic
sublines. Map distances in centiMorgans (cM) and in Megabasepairs (Mbp) are based on the
SHRSP x BN genetic map (http://rgd.mcw.edu/) and RGSC3.4, Ensembl release 45
respectively. Black bars represent the chromosomal region transferred from the BN strain,
white bars from the SHR background and grey bars represent the recombination zones. The
dashed lines represent the limits of the salt sensitivity and blood pressure regulatory regions.
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Figure 2.
Systolic blood pressure measured by radiotelemetry in (a) 15–17 week old SHR and
SHR-18, (b) 19–21 week old SHR and SHR-18A, (c) 15–17 week old SHR and SHR-18B,
(d) 15–17 week old SHR and SHR-18C strains. Baseline systolic blood pressure was
significantly reduced in SHR-18 (F1,12=4.84; P=0.048), SHR-18A (F1,12=10.17; P=0.008)
and SHR-18B (F1,11=12.6; P=0.005). No significant reduction in systolic blood pressure was
obtained in SHR-18C (F1,11=0.27; P=0.61) strain vs SHR. All results according to main
effect F values of two way repeated measures ANOVA are reported. Salt-loaded systolic
blood pressure was significantly raised in all SHR and congenic strains SHR-18A (F1,6
=27.7; P= 0.002), SHR-18B (F1,4 =57.3; P= 0.0016) and SHR-18C (F1,6 =10.3; P= 0.019)
with the exception of SHR-18: SHR-18 (F1,7 =0.88; P= 0.38). All F values computed for
contrast comparison in two-way ANOVA. The baseline period is from −12 to −2 days and
salt administration from day 1 as indicated. Values displayed are means ± SEM.
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Figure 3.
Transplant recipients’ systolic blood pressure during normal and high salt intake (1% NaCl
as drinking water) measured by radiotelemetry at the age of 18–20 weeks. Reduction in
baseline systolic blood pressure near the significance level was achieved in SHRSHR18
(F1,11=4.50; P=0.057) vs SHRSHR transplanted rats. All results according to main effect F
values of two way repeated measures ANOVA. Salt-loaded systolic blood pressure was
significantly raised in SHRSHR-18 (F=101.6; P<0.0001). All F values computed for contrast
comparison in two-way ANOVA. The baseline and salt administration period is indicated as
in Figure 2.
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Figure 4.
Northern blot of SHR and BN kidney small RNA, probed with an antisense oligonucleotide
derived from the extended RACE product for Affymetrix probe set rc_AA957526_at rat
sequence with 5S rRNA as a loading control.
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